Related references
Note: Only part of the references are listed.PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders
Andrew Siderowf et al.
BMC NEUROLOGY (2014)
What can biomarkers tell us about cognition in Parkinson's disease?
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2014)
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2014)
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions
Rik Ossenkoppele et al.
NEUROLOGY (2014)
CSF Aβ42 predicts early-onset dementia in Parkinson disease
Guido Alves et al.
NEUROLOGY (2014)
The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
S. A. Vann Jones et al.
PSYCHOLOGICAL MEDICINE (2014)
Impact of molecular imaging on the diagnostic process in a memory clinic
Rik Ossenkoppele et al.
ALZHEIMERS & DEMENTIA (2013)
Aβ amyloid, cognition, and APOE genotype in healthy older adults
Yen Ying Lim et al.
ALZHEIMERS & DEMENTIA (2013)
Comparing Positron Emission Tomography Imaging and Cerebrospinal Fluid Measurements of β-Amyloid
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2013)
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease
Guido Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
Marti Colom-Cadena et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging
Roger L. Albin et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients
Dean F. Wong et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
β-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy
Hitoshi Shimada et al.
MOVEMENT DISORDERS (2013)
-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia
Martijn L. T. M. Mueller et al.
MOVEMENT DISORDERS (2013)
The many faces of alpha-synuclein mutations
Meike Kasten et al.
MOVEMENT DISORDERS (2013)
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
Stephen N. Gomperts et al.
NEUROLOGY (2013)
Meta-analysis of amyloid-cognition relations in cognitively normal older adults
Trey Hedden et al.
NEUROLOGY (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Neuropathology of dementia in a large cohort of patients with Parkinson's disease
Judit Horvath et al.
PARKINSONISM & RELATED DISORDERS (2013)
Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study
Milos D. Ikonomovic et al.
ACTA NEUROPATHOLOGICA (2012)
Neuropathologic substrates of Parkinson disease dementia
David J. Irwin et al.
ANNALS OF NEUROLOGY (2012)
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2012)
Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
Paul T. Kotzbauer et al.
ARCHIVES OF NEUROLOGY (2012)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies
Jonathan Graff-Radford et al.
BRAIN (2012)
Biomarkers in dementia with Lewy bodies: a review
Namrta Sinha et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Interaction between pathogenic proteins in neurodegenerative disorders
Kurt A. Jellinger
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Brain amyloid and cognition in Lewy body diseases
Stephen N. Gomperts et al.
MOVEMENT DISORDERS (2012)
Multimodality imaging characteristics of dementia with Lewy bodies
Kejal Kantarci et al.
NEUROBIOLOGY OF AGING (2012)
Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
Kejal Kantarci et al.
NEUROBIOLOGY OF AGING (2012)
APOE modifies the association between A beta load and cognition in cognitively normal older adults
K. Kantarci et al.
NEUROLOGY (2012)
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia
Myria Petrou et al.
NEUROLOGY (2012)
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline A multicenter study
P. Murali Doraiswamy et al.
NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease
Victor L. Villemagne et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography
James F. Burke et al.
BRAIN (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
Victor L. Villemagne et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
MDS Task Force on Mild Cognitive Impairment in Parkinson's Disease: Critical Review of PD-MCI
Irene Litvan et al.
MOVEMENT DISORDERS (2011)
Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
M. E. Kalaitzakis et al.
NEUROBIOLOGY OF DISEASE (2011)
Amyloid and glucose imaging in dementia with Lewy bodies systems atrophy
Daniel O. Claassen et al.
PARKINSONISM & RELATED DISORDERS (2011)
Florbetapir F-18: A Histopathologically Validated Beta-Amyloid Positron Emission Tomography Imaging Agent
John Lister-James et al.
SEMINARS IN NUCLEAR MEDICINE (2011)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
Rik Vandenberghe et al.
ANNALS OF NEUROLOGY (2010)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Amyloid Imaging of Lewy Body-Associated Disorders
Erin R. Foster et al.
MOVEMENT DISORDERS (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
M. A. Burack et al.
NEUROLOGY (2010)
11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage
J. V. Ly et al.
NEUROLOGY (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia
Hiroshige Fujishiro et al.
NEUROSCIENCE LETTERS (2010)
[11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia
Pekka Jokinen et al.
PARKINSONISM & RELATED DISORDERS (2010)
Parkinson Disease With Dementia Comparing Patients With and Without Alzheimer Pathology
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
A clinico-pathological study of subtypes in Parkinson's disease
M. Selikhova et al.
BRAIN (2009)
Neuropathology of Lewy body disorders
Enikoe Koevari et al.
BRAIN RESEARCH BULLETIN (2009)
C-11-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease
V. L. Villemagne et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
Natalie Nelissen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics
Walter Maetzler et al.
NEUROBIOLOGY OF DISEASE (2009)
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2008)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
P. Edison et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
[11C]PIB binding in Parkinson's disease dementia
Walter Maetzler et al.
NEUROIMAGE (2008)
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease
Alexander Drzezga et al.
NEUROIMAGE (2008)
Imaging amyloid deposition in Lewy body diseases
S. N. Gomperts et al.
NEUROLOGY (2008)
[C-11]-PIB imaging in patients with Parkinson's disease: Preliminary results
A. Johansson et al.
PARKINSONISM & RELATED DISORDERS (2008)
PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis
A. Lockhart et al.
BRAIN (2007)
In vitro characterization of Pittsburgh compound-B binding to Lewy bodies
Michelle T. Fodero-Tavoletti et al.
JOURNAL OF NEUROSCIENCE (2007)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2007)
Imaging β-amyloid burden in aging and dementia
C. C. Rowe et al.
NEUROLOGY (2007)
DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa et al.
NEUROLOGY (2007)
Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report
Brian J. Bacskai et al.
ARCHIVES OF NEUROLOGY (2007)
Predictors of survival in dementia with Lewy bodies and Parkinson dementia
Kurt A. Jellinger et al.
NEURODEGENERATIVE DISEASES (2007)
PET of brain amyloid and tau in mild cognitive impairment
Gary W. Small et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
C. Ballard et al.
NEUROLOGY (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Guido Alves et al.
MOVEMENT DISORDERS (2006)
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies
DJ Burn et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
The 2,6-disubstituted naphthalene derivative FDDNP labeling reliably predicts congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases
LM Smid et al.
BRAIN PATHOLOGY (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain
WE Klunk et al.
JOURNAL OF NEUROSCIENCE (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
CA Mathis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
Relation between clinical characteristics of Parkinson's disease and cognitive decline
JJ Locascio et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2003)
Dementia with Lewy bodies: Neuropathology
DW Dickson
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2002)
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
KA Jellinger et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies
K Kanemaru et al.
NEUROLOGY (2000)
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
IG McKeith et al.
NEUROLOGY (2000)
Cholinergic dysfunction in diseases with Lewy bodies
P Tiraboschi et al.
NEUROLOGY (2000)
Share Paper
